Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glycoprotein Ib platelet subunit alpha | 0.565 | 0.692 | 3.2E-03 |
|
disease | 1.000 | None | 1.000 | 0 | 1 | 1990 | 2020 | ||||||||
|
glycoprotein Ib platelet subunit beta | 0.524 | 0.769 | 0.51 |
|
disease | 1.000 | definitive | 1.000 | 0 | 3 | 1988 | 2019 | ||||||||
|
UbiA prenyltransferase domain containing 1 | 0.700 | 0.462 | 2.0E-02 |
|
disease | 1.000 | strong | 0.957 | 0 | 10 | 2007 | 2019 | ||||||||
|
huntingtin | 0.548 | 0.654 | 1.00 |
|
disease | 1.000 | limited | 0.987 | 0 | 1 | 1993 | 2020 | ||||||||
|
hepatocyte nuclear factor 4 alpha | 0.461 | 0.808 | 0.15 |
|
disease | 1.000 | None | 0.942 | 0 | 1 | 1992 | 2019 | ||||||||
|
homeobox A13 | 0.552 | 0.654 | 0.96 |
|
disease | 1.000 | None | 1.000 | 0 | 4 | 1971 | 2019 | ||||||||
|
homeobox D13 | 0.483 | 0.808 | 8.6E-03 |
|
disease | 1.000 | None | 0.978 | 0 | 9 | 1993 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 1.000 | strong | 1.000 | 0 | 2 | 1978 | 2018 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 1.000 | limited | 0.982 | 0 | 2 | 1992 | 2020 | ||||||||
|
integrin subunit beta 3 | 0.485 | 0.846 | 1.7E-03 |
|
disease | 1.000 | definitive | 1.000 | 0 | 12 | 1982 | 2020 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 1.000 | None | 0.975 | 0 | 1 | 2005 | 2020 | ||||||||
|
potassium voltage-gated channel subfamily A member 1 | 0.573 | 0.577 | 7.6E-02 |
|
disease | 1.000 | None | 0.974 | 0 | 12 | 1994 | 2018 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 10 | 0.599 | 0.654 | 0.15 |
|
disease | 1.000 | strong | 1.000 | 0 | 11 | 1997 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 1.000 | None | 1.000 | 0 | 10 | 1991 | 2018 | ||||||||
|
keratin 1 | 0.575 | 0.654 | 0.74 |
|
disease | 1.000 | None | 0.951 | 0 | 7 | 1992 | 2019 | ||||||||
|
L1 cell adhesion molecule | 0.475 | 0.769 | 1.00 |
|
disease | 1.000 | None | 0.984 | 0 | 11 | 1986 | 2020 | ||||||||
|
L1 cell adhesion molecule | 0.475 | 0.769 | 1.00 |
|
disease | 1.000 | definitive | 1.000 | 0 | 6 | 1986 | 2019 | ||||||||
|
LDL receptor related protein 5 | 0.485 | 0.846 | 0.51 |
|
disease | 1.000 | None | 1.000 | 0 | 20 | 2001 | 2017 | ||||||||
|
myelin protein zero | 0.503 | 0.846 | 0.27 |
|
disease | 1.000 | None | 1.000 | 0 | 5 | 1992 | 2019 | ||||||||
|
tripartite motif containing 37 | 0.610 | 0.654 | 9.7E-12 |
|
disease | 1.000 | None | 1.000 | 0 | 13 | 1999 | 2020 | ||||||||
|
myosin heavy chain 9 | 0.505 | 0.808 | 1.00 |
|
phenotype | 1.000 | definitive | 1.000 | 0 | 13 | 1998 | 2020 | ||||||||
|
norrin cystine knot growth factor NDP | 0.566 | 0.692 | 0.65 |
|
disease | 1.000 | definitive | 1.000 | 0 | 17 | 1992 | 2019 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
group | 1.000 | strong | 0.941 | 0 | 10 | 1992 | 2019 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 1.000 | strong | 0.957 | 0 | 20 | 1995 | 2015 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
disease | 1.000 | limited | 0.974 | 0 | 5 | 1999 | 2018 |